ScholarLens Back to search
2001•Drug SafetyRequires access

Increased Risk of Somnolence with the New Dopamine Agonists in Patients with Parkinson??s Disease

Mahyar Etminan, Ali Samii, Bahi Takkouche, Paula A. Rochon

Open publisher page 65 citations

Abstract

This record does not include an abstract. Use the full-text link above if available.

About this research paper

What this paper is about

An abstract is not available in the OpenAlex record for this paper.

Why it matters

OpenAlex reports 65 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Key concepts: Ropinirole, Pramipexole, Somnolence, Medicine, Levodopa, Placebo, Relative risk, Parkinson's disease

Related papers

Related paper 1Related paper 2Related paper 3
Back to paper searchBrowse research topicsOriginal source
Increased Risk of Somnolence with the New Dopamine Agonists in Patients with Parkinson??s Disease — Research Paper | ScholarLens